Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Klomp

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biochemical Society Transactions|February 5, 2021
The ERK mitogen-activated protein kinase signaling network: the final frontier in RAS signal transductionJennifer E Klomp, Jeff A Klomp, Channing J Der
Journal of Virology|January 30, 2009
Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitroSebla B Kutluay, Sarah L DeVos, Jennifer E Klomp, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Dissecting Kinase Effector Signaling Using the RapRTAP MethodologyAnne-Marie Ray, Jennifer E Klomp, Kerrie B Collins, et al.
The Journal of Biological Chemistry|February 20, 2020
Comprehensive transcriptomic profiling reveals SOX7 as an early regulator of angiogenesis in hypoxic human endothelial cellsJeff Klomp, James Hyun, Jennifer E Klomp, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Mimicking transient activation of protein kinases in living cellsJennifer E Klomp, Vincent Huyot, Anne-Marie Ray, et al.
The Journal of Cell Biology|December 23, 2019
Septin2 mediates podosome maturation and endothelial cell invasion associated with angiogenesisKerrie B Collins, Hojin Kang, Jacob Matsche, et al.
Genes & Cancer|March 16, 2023
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in <i>KRAS</i>-mutant pancreatic cancerYe S Lee, Jennifer E Klomp, Clint A Stalnecker, et al.
Cell Chemical Biology|May 28, 2019
Time-Variant SRC Kinase Activation Determines Endothelial Permeability ResponseJennifer E Klomp, Mark Shaaya, Jacob Matsche, et al.
Cancer Research|November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C InhibitorsA Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.
The Journal of Biological Chemistry|October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancerJ Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biochemical Society Transactions|February 5, 2021
The ERK mitogen-activated protein kinase signaling network: the final frontier in RAS signal transductionJennifer E Klomp, Jeff A Klomp, Channing J Der
Journal of Virology|January 30, 2009
Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitroSebla B Kutluay, Sarah L DeVos, Jennifer E Klomp, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Dissecting Kinase Effector Signaling Using the RapRTAP MethodologyAnne-Marie Ray, Jennifer E Klomp, Kerrie B Collins, et al.
The Journal of Biological Chemistry|February 20, 2020
Comprehensive transcriptomic profiling reveals SOX7 as an early regulator of angiogenesis in hypoxic human endothelial cellsJeff Klomp, James Hyun, Jennifer E Klomp, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Mimicking transient activation of protein kinases in living cellsJennifer E Klomp, Vincent Huyot, Anne-Marie Ray, et al.
The Journal of Cell Biology|December 23, 2019
Septin2 mediates podosome maturation and endothelial cell invasion associated with angiogenesisKerrie B Collins, Hojin Kang, Jacob Matsche, et al.
Genes & Cancer|March 16, 2023
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in <i>KRAS</i>-mutant pancreatic cancerYe S Lee, Jennifer E Klomp, Clint A Stalnecker, et al.
Cell Chemical Biology|May 28, 2019
Time-Variant SRC Kinase Activation Determines Endothelial Permeability ResponseJennifer E Klomp, Mark Shaaya, Jacob Matsche, et al.
Cancer Research|November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C InhibitorsA Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.
The Journal of Biological Chemistry|October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancerJ Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Pageof 3